Board Meeting12 Jun 2026, 05:41 pm
Biogen Pharmachem: Trading Window Closed for Q1 FY27 Results
AI Summary
Biogen Pharmachem Industries Ltd has announced the closure of its trading window for dealing in company securities. The window will be closed from Wednesday, July 1, 2026, until 48 hours after the declaration of the unaudited financial results for the first quarter ended June 30, 2026. This action is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct. The date for the upcoming Board Meeting to consider these financial results will be communicated in due course.
Key Highlights
- Trading window closed from July 1, 2026.
- Closure is for Q1 FY27 unaudited financial results.
- Window reopens 48 hours post-results declaration.
- Board meeting date for results to be announced later.
- Action complies with SEBI Insider Trading Regulations.
Price Impact
More from BIOGEN